ReShape Lifesciences Inc. (NASDAQ: RSLS) Stock Information | RedChip

ReShape Lifesciences Inc. (NASDAQ: RSLS)


$5.8200
+0.2400 ( +2.65% ) 16.0K

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Market Data


Open


$5.8200

Previous close


$5.5800

Volume


16.0K

Market cap


$4.10M

Day range


$5.5150 - $5.9100

52 week range


$4.6000 - $34.2200

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 63 Nov 14, 2024
8-k 8K-related 16 Nov 14, 2024
8-k 8K-related 20 Oct 17, 2024
8-k 8K-related 17 Sep 24, 2024
8-k 8K-related 16 Aug 14, 2024
10-q Quarterly Reports 62 Aug 14, 2024
4 Insider transactions 1 Aug 13, 2024
8-k 8K-related 21 Jul 09, 2024
8-k 8K-related 16 May 20, 2024
10-q Quarterly Reports 60 May 15, 2024

Latest News